pharmacogenomics
Doctors and patient advocates supporting pretreatment testing at times challenged FDA and other experts who aren't swayed by available evidence.
Mass General Brigham Becomes Latest US Health System to Adopt Pretreatment DPYD Testing
The change in policy at the health system follows the death of a DPD deficient patient and comes during a period of intense competition among Boston hospitals.
New York State DOH Approves Solvd Lab for Clinical PGx Testing
The company markets an assay intended to predict patients' risk of developing opioid use disorder, helping physicians tailor their use of these drugs.
New European Project to Fund PGx for Personalized Medicine Research With €36.5M
Earlier this week, EP PerMed issued its second joint transnational call for proposals for the PGxPM2025 project involving 35 funding organizations.
UBS Initiates Coverage of Myriad Genetics With Neutral Rating
Analysts noted that while continued double-digit growth appears unsustainable in the near term, risks related to UnitedHealthcare's decision on pharmacogenetic testing appear limited.